| 标题 |
Abstract PD11-04: PD11-04 Primary results of SOLTI-1503 PROMETEO phase 2 trial of Combination of Talimogene Laherparepvec (T-VEC) with Atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:Tomás Pascual; Maria Vidal; Juan Miguel Cejalvo; Estela Vega; Esther Sanfeliu; et al 出版日期:2023-03-02 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)